Table 1.

Pretreatment Clinical Characteristics of Myeloid/NK Cell Precursor Acute Leukemia Cases

Case No.Age (yr)/SexWBC% BlastsHbPLTBM InvolvementSite of Involvement
(×109/L)(g/dL)(×109/L)Diagnosis (relapse)LNLiverSpleenMediastinum
34/M 8.8 0% 17.0 381  0% (81.0%) Neck, axillary, inguinal − − − 
46/M 51.0 87% 14.4 39 86.5% Neck 
54/M 2.1 29% 15.2 86 89.5% Neck, axillary, tonsil − − − 
29/F 1.1 5% 12.6 76 91.5% Submandible, neck − − − 
48/M 5.9 0% 15.7 217  0% (56.0%)  —  − − 
19/M 1.3 11% 14.0 258 78.0% Neck, inguinal − − − 
59/M 2.7 5% 13.0 199 19.5% (84.0%) Neck, axillary, inguinal − − − 
Case No.Age (yr)/SexWBC% BlastsHbPLTBM InvolvementSite of Involvement
(×109/L)(g/dL)(×109/L)Diagnosis (relapse)LNLiverSpleenMediastinum
34/M 8.8 0% 17.0 381  0% (81.0%) Neck, axillary, inguinal − − − 
46/M 51.0 87% 14.4 39 86.5% Neck 
54/M 2.1 29% 15.2 86 89.5% Neck, axillary, tonsil − − − 
29/F 1.1 5% 12.6 76 91.5% Submandible, neck − − − 
48/M 5.9 0% 15.7 217  0% (56.0%)  —  − − 
19/M 1.3 11% 14.0 258 78.0% Neck, inguinal − − − 
59/M 2.7 5% 13.0 199 19.5% (84.0%) Neck, axillary, inguinal − − − 

Abbreviations: LN, lymph node; BM, bone marrow; WBC, white blood cell count; Hb, hemoglobin level; PLT, platelet count.

or Create an Account

Close Modal
Close Modal